Development of a Biorelevant Dissolution Test Using Bicarbonate Buffer and Apex Vessel to Predict Clinical Bioequivalence.

Fushimi M, Nakamichi K, Nakatani M, Sugano K

Open source

DOI
10.1248/cpb.c25-00583
Published
2026
Container
Chemical & pharmaceutical bulletin
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1248/cpb.c25-00583,
  title = {Development of a Biorelevant Dissolution Test Using Bicarbonate Buffer and Apex Vessel to Predict Clinical Bioequivalence.},
  author = {Fushimi M and Nakamichi K and Nakatani M and Sugano K},
  year = {2026},
  journal = {Chemical \& pharmaceutical bulletin},
  doi = {10.1248/cpb.c25-00583},
  url = {https://doi.org/10.1248/cpb.c25-00583}
}

RIS

TY  - JOUR
TI  - Development of a Biorelevant Dissolution Test Using Bicarbonate Buffer and Apex Vessel to Predict Clinical Bioequivalence.
AU  - Fushimi M
AU  - Nakamichi K
AU  - Nakatani M
AU  - Sugano K
PY  - 2026
JO  - Chemical & pharmaceutical bulletin
DO  - 10.1248/cpb.c25-00583
UR  - https://doi.org/10.1248/cpb.c25-00583
ER  - 

APA

M, F., K, N., M, N., & K, S. (2026). Development of a Biorelevant Dissolution Test Using Bicarbonate Buffer and Apex Vessel to Predict Clinical Bioequivalence.. Chemical & pharmaceutical bulletin. https://doi.org/10.1248/cpb.c25-00583

Source records